Detailed price information for Innocan Pharma Corp (INNPF) from The Globe and Mail including charting and trades.

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), announced today a settlement and license agreement with ...

BRIDGEWATER, N.J. and BENGALURU, Karnataka, India, April 15, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon ...

Global business visionary, inventor, and philanthropist leaves behind a legacy of improving billions of lives around the ...

Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is pleased to announce the upcoming publication of its patent for an innovative enzymatic method to ...

It was a busy week for the biotech sector, with lots of regulatory ... Among these, Pacira Biosciences, Inc. PCRX was up on a positive patent settlement agreement, while Edgewise Therapeutics ...

Colossal’s woolly mammoth patent application, with its descriptions of modified cells and animals, represents “the current ...

The issuance of this patent marks another key milestone as FluidForm Bio continues to build a strong and defensible IP portfolio and extend its leadership in bioprinted regenerative medicine. The ...

The EXTRAClean Exosomal RNA Isolation Kit produces high-quality RNA that improves results from small RNA sequencing and ...

The NIT-R was granted a patent for the bio-ink on March 18. The research team, led by associate professor of the Department of Biotechnology and Medical Engineering Prof Devendra Verma ...

The rise of AI in health care presents new challenges related to the patentability and regulation of AI-driven medical ...